Efficacy of carboplatin-taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials

ダウンロード数 : ? 件

この文献の参照には次のURLをご利用ください : https://ir.lib.shimane-u.ac.jp/53977

言語	英語
著者	Regan M. M. Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA O'Donnell E. K. Beth Israel Deaconess Medical Center, Boston, MA Kelly W. K. Department of Medicine and Surgery, Yale University, New Haven, CT Halabi S. Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC Berry W. US Oncology, Inc., Houston, TX ／ Cancer Centers of North Carolina, Cary, NC, USA Urakami S. Department of Urology, Shimane University School of Medicine, Izumo, Japan Kikuno N. Department of Urology, Shimane University School of Medicine, Izumo, Japan Oh W. K. Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
主題	carboplatin; estramustine; prostate cancer; taxanes
掲載誌名	ANNALS OF ONCOLOGY
巻	21
号	2
開始ページ	312
終了ページ	318
ISSN	0923-7534
発行日	2010-02
DOI	10.1093/annonc/mdp308
PubMed ID	19633053
出版者	OXFORD UNIV PRESS
資料タイプ	学術雑誌論文
部局	医学部